Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Methimazole measurement |
Has measured component |
False |
Methimazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methimazole measurement |
Component |
True |
Methimazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely thiamazole 500 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methimazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely thiamazole 5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methimazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Thiamazole 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methimazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing thiamazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methimazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Thiamazole 15 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methimazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Thiamazole 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methimazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methimazole embryofetopathy |
Causative agent (attribute) |
True |
Methimazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely thiamazole 500 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methimazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely thiamazole 500 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Methimazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely thiamazole 5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methimazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely thiamazole 5 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Methimazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Thiamazole 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methimazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Thiamazole 10 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Methimazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Thiamazole 15 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methimazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Thiamazole 15 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Methimazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Thiamazole 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methimazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Thiamazole 20 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Methimazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely thiamazole 500 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Methimazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Thiamazole 20 mg oral tablet |
Has precise active ingredient |
True |
Methimazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Thiamazole-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methimazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Thiamazole 10 mg oral tablet |
Has precise active ingredient |
True |
Methimazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Thiamazole 15 mg oral tablet |
Has precise active ingredient |
True |
Methimazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely thiamazole 5 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Methimazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only thiamazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methimazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only thiamazole in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methimazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |